Agent, absorbable hemostatic, non-collagen based
PMA 核准號：P210036 · 2026-08-07
廣告
決定日期2026-08-07
PMA 編號P210036
產品代碼LMG
器械分類3 類
醫療專科G
法規編號21 CFR 8
諮詢委員會SU
請提供完整的描述文本，以便我進行翻譯。
器材摘要
Agent, absorbable hemostatic, non-collagen based is the device name listed in this FDA 510(k) record. The listed applicant is Baxter Healthcare Corporation. It received FDA 510(k) clearance on 2026-08-07. The device is classified under product code LMG. It was reviewed by the SU advisory panel.
常見問題
What is the Agent, absorbable hemostatic, non-collagen based?
Agent, absorbable hemostatic, non-collagen based is a medical device that received FDA 510(k) clearance on 2026-08-07. The listed applicant is Baxter Healthcare Corporation.
When did Agent, absorbable hemostatic, non-collagen based receive FDA 510(k) clearance?
The clearance date for Agent, absorbable hemostatic, non-collagen based can be found in the official FDA records.
誰是列於「Agent, 可吸收止血劑，非膠原質基質」的申請人？
The FDA 510(k) record lists Baxter Healthcare Corporation as the applicant. This does not by itself establish the device manufacturer.
FDA產品代碼為Agent，可吸收止血劑，非膠原質基質的是什麼？
FDA產品代碼為Agent，可吸收止血，非膠原基質的為LMG。
相關臨床試驗
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
官方來源
在 FDA 資料庫中查看 →資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。
廣告